Both CSF and plasma TDP-43 were higher in patients with ALS compared to controls in the discovery cohort, but, in the validation cohort, only CSF TDP-43 was elevated in ALS compared to controls. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.